Skip to main content
SpringerLink
Log in

Clinical Use of Indocyanine Green (ICG) Kinetics in Liver Anaesthesia and ICU

  • Chapter
Practical Issues Updates in Anesthesia and Intensive Care

  • 1868 Accesses

Abstract

This chapter provides an updated and critical review of the use of indocyanine green (ICG) kinetics as a dynamic assessment of liver function using the new noninvasive bedside monitors now available in clinical practice. The analysis encompasses the most common indications ICG has today in clinical practice [1]: the diagnostic and prognostic role in the perioperative period of major liver surgery and liver transplantation [2] and the role in the critically ill patients in ICU to predict mortality and to assess the impact of intraabdominal hypertension on splanchnic perfusion.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Bibliography

  1. Hawker F (1993) The liver, chap 1. Saunders Co., London, UK, pp 1–43

    Google Scholar 

  2. Mulaikal TA, Edmond JC (2012) Physiology and anatomy of the liver: chap 1. In: Wagener G (ed) Liver anesthesiology and critical care medicine. Springer, New York, pp 3–20

    Chapter  Google Scholar 

  3. Sakka SG (2007) Assessing liver function. Curr Opin Crit Care 13:207–214

    Article  PubMed  Google Scholar 

  4. Hoekstra LT, De Graaf W, Niboug G, Heger M, Bennick JR, Stieger B, Van Gulik TM (2013) Physiological and biochemical basis of clinical liver function tests. Ann Surg 257:1–27

    Article  Google Scholar 

  5. Dufour DR, Qazi N (2012) Evaluation of liver disease: chap 4. In: Wagener G (ed) Liver anesthesiology and critical care medicine. Springer, New York, pp 51–58

    Chapter  Google Scholar 

  6. Slack A, Ladher N, Wendon J (2012) Acute hepatic failure: chap 2. In: Wagener G (ed) Liver anesthesiology and critical care medicine. Springer, New York, pp 21–41

    Chapter  Google Scholar 

  7. Wagener G (2013) Assessment of hepatic function, operative candidacy, and medical management after liver resection in the patient with underlying liver disease. Semin Liver Dis 33:204–212

    Article  PubMed  Google Scholar 

  8. Imamura H, Sano K, Sugawara S, Kukudo N, Makuuchi M et al (2005) Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg 12:16–22

    Article  PubMed  Google Scholar 

  9. Vos JJ, Wietasch JKG, Absalom AR, Hendriks HGD, Scheeren TWL (2014) Green light for liver function monitoring using indocyanine green? An overview of current clinical application. Anesthesia. doi:10.1111/anae.12755

    Google Scholar 

  10. Halle BM, Poulsen TD, Pedersen HP (2014) Indocyanine green plasma disappearance rate as dynamic liver function test in critically ill patients. Acta Anesthesiol Scand 58:1214–1219

    Article  CAS  Google Scholar 

  11. Mizuguchi T, Kawamoto M, Meguro M, Hui TT, Hirata K (2014) Preoperative liver function assessments to estimate the prognosis and safety of liver resections. Surg Today 44:1–10

    Article  PubMed  Google Scholar 

  12. Leevy CM, Mendenhall CL, Lesko W, Howard MM (1962) Estimation of hepatic blood flow with indocyanine green. J Clin Invest 41:1169–1180

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Pessayre D, Lebrec D, Descantoire V et al (1978) Mechanism for reduced drug clearance in patients with cirrhosis. Gastroenterology 74:566–571

    CAS  PubMed  Google Scholar 

  14. Paumgartner G, Probst P, Kraines R, Leevy CM (1970) Kinetics of indocyanine green removal from the blood. N Y Acad Sci 170:134–147

    Article  CAS  Google Scholar 

  15. Lau H, Man K, Fan ST et al (1997) Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 84:1255–1259

    Article  CAS  PubMed  Google Scholar 

  16. Shinohara H, Tanaka A, Kital T et al (1996) Direct measurement of hepatic indocyanine green clearance with near-infrared spectroscopy: separate evaluation of uptake and removal. Hepatology 23:137–144

    Article  CAS  PubMed  Google Scholar 

  17. Cui Y, Konig J, Leier J et al (2001) Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J Biol Chem 276:9626–9636

    Article  CAS  PubMed  Google Scholar 

  18. Keiding S (1987) Hepatic clearance and liver blood flow. J Hepatol 4:393–398

    Article  CAS  PubMed  Google Scholar 

  19. Kawasaki S, Sugiyama Y, Yga T et al (1985) Pharmacokinetic study on the hepatic uptake of indocyanine green in cirrhotic patients. Am J Gastroenterol 80:801–806

    CAS  PubMed  Google Scholar 

  20. Huet PM, Goresky CA, Villeneuve JP et al (1982) Assessment of liver microcirculation in cirrhosis. J Clin Invest 70:1234–1244

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Ge PL, Du SD, Mao YL (2014) Advances in preoperative assessment of liver function. Hepatobiliary Pancreat Dis Int 13:361–370

    Article  PubMed  Google Scholar 

  22. Faybik P, Krenn C-G, Baker A, Lahner D, Berlakovich G, Steltzer H, Hetz H (2004) Comparison of invasive and noninvasive measurement of plasma disappearance rate of indocyanine green in patients undergoing liver transplantation: a prospective investigator-blinded study. Liver Transpl 10:1060–1064

    Article  PubMed  Google Scholar 

  23. Kisch H, Leucht S, Lichtwarck-Aschoff M et al (1995) Accuracy and reproducibility of the measurement of actively circulating blood volume with an integrated fiberoptic monitoring system. Crit Care Med 23:885–893

    Article  CAS  PubMed  Google Scholar 

  24. Aoyagi T, Fuse M et al (1994) Pulse dye-densitometry. Jpn J Clin Monit 5:371

    Google Scholar 

  25. Sakka SG, Reinhart K, Meier Hellmann A (2000) Comparison of invasive and non invasive measurements of indocyanine green plasma disappearance rate in critically ill patients with mechanical ventilation and stable hemodynamics. Intensive Care Med 26:1553–1556

    Article  CAS  PubMed  Google Scholar 

  26. Purcell R, Kruger P, Jones M (2006) Indocyanine green elimination: a comparison of the Limon and serial blood sampling methods. ANZ J Surg 76:75–77

    Article  PubMed  Google Scholar 

  27. Mazza E, Prosperi M, DeGasperi A et al (2008) Plasma disappearance rate of indocyanine green after liver transplantation: always a reliable tool to predict graft function and out come? Liver Transpl 14:S201

    Google Scholar 

  28. Manizate F, Hiotis SP, Labow D et al (2010) Liver functional reserve estimation: state of the art and relevance for local treatments. J Hepatobiliary Pancreat Sci 17:385–388

    Article  PubMed  Google Scholar 

  29. Imamura H, Makuuchi M et al (2003) One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 138:1198–1206

    Article  PubMed  Google Scholar 

  30. Bellavanca EC, Lumpkins KM et al (2008) Surgical management of early – stage hepatocellular carcinoma: resection or transplantation ? J Gastrointest Surg 12:1699–1708

    Article  Google Scholar 

  31. Jarnagin W, Gonen M, Fong Y et al (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1803 consecutives cases over the past decade. Ann Surg 236:397–407

    Article  PubMed Central  PubMed  Google Scholar 

  32. Fan ST (2010) Liver functional estimation: state of art and relevance for local treatments: the eastern perspective. J Hepatobiliary Pancreat Sci 17:380–384

    Article  PubMed  Google Scholar 

  33. Bruix J, Castells A, Bossch J et al (1996) Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 111:1018–1022

    Article  CAS  PubMed  Google Scholar 

  34. Lee S, Shin Hwang (2005) How I do it: assessment of hepatic functional reserve for indication of hepatic resection. J Hepatobiliary Pancreat Surg 12:38–43

    Article  PubMed  Google Scholar 

  35. Poon RT, Fan ST (2005) Assessment of hepatic reserve for indication of hepatic resection: how I do it. J Hepatobiliary Pancreat Surg 12:31–37

    Article  PubMed  Google Scholar 

  36. Nonami T, Nakao A et al (1999) Blood loss and ICG clearance as best prognostic markers of post-hepatectomy liver failure. Hepatogastroenterology 46:1669–1672

    CAS  PubMed  Google Scholar 

  37. Janssen MW, Druckerey-Fiskaaen KY et al (2010) Indocyanine green R 15 ratio depends directly on liver perfusion flow rate. J Hepatobiliary Pancreat Sci 17:180–185

    Article  PubMed  Google Scholar 

  38. Capussotti L, Viganò L et al (2009) Liver dysfunction and sepsis determine operative mortality after liver resection. Br J Surg 96:88–94

    Article  CAS  PubMed  Google Scholar 

  39. TurcotteJ G, Child GG (1964) Surgery and portal hypertension. Major Probl Clin Surg 1:1–85

    Google Scholar 

  40. Pugh RWH, Murray –Lyon IM et al (1983) Transection of the esophagus for bleeding esophageal varices. Br J Surg 60:646–649

    Article  Google Scholar 

  41. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31:864–871

    Article  CAS  PubMed  Google Scholar 

  42. Dutkowski P, Oberkofler CE, Béchir M, Müllhaupt B, Geier A, Raptis DA et al (2011) The model for end-stage liver disease allocation system for liver transplantation saves lives, but increases morbidity and cost: a prospective outcome analysis. Liver Transpl 17:674–684

    Article  PubMed  Google Scholar 

  43. Cholongitas E, Marelli L, Shusang V et al (2006) A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transpl 12:1049–1061

    Article  PubMed  Google Scholar 

  44. Cucchetti A, Ercolani G, Vivarelli M et al (2006) Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on liver cirrhosis. Liver Transpl 12(6):966–971

    Article  PubMed  Google Scholar 

  45. Teh SH, Christein J et al (2005) Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality. J Gastrointest Surg 9:1207–1215

    Article  PubMed  Google Scholar 

  46. Hemming AW, Scudamore CH, Shackleton CR, Pudek M, Erb SR (1992) Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients. Am J Surg 163:515–518

    Article  CAS  PubMed  Google Scholar 

  47. Lam CM, Fan S, lo CM, Wong J (1999) Major hepatectomy for hepatocellular carcinoma in patients with an unsatisfactory indocyanine green clearance test. Br J Surg 86:1012–1017

    Article  CAS  PubMed  Google Scholar 

  48. Kokudo N, Makuuchi M (2009) Evidence–based clinical practice guidelines for hepatocellular carcinoma in Japan: the Japan _HCC guidelines. J Gastroenterol 44:119–121

    Article  PubMed  Google Scholar 

  49. Ohwada S, Kawate S, Hamada K et al (2006) Perioperative real time monitoring of indocyanine green clearance by pulse spectrophotometry predicts remnant liver functional reserve in resection of hepatocellular carcinoma. Br J Surg 93:339–346

    Article  CAS  PubMed  Google Scholar 

  50. Greco E, Nanji S, Bromberg IL, Shah S, Wei AC, Moulton C-A, Greig PD, Gallinger S, Cleary SP (2011) Predictors of periopertative morbidity and liver dysfunction after hepatic resection in patients with chronic liver disease. HPB (Oxford) 13:559–565

    Article  Google Scholar 

  51. Shindoh JD, Tzeng CW, Vauthey JN (2012) Portal vein embolization for hepatocellular carcinoma. Liver Cancer 1:159–167

    Article  PubMed Central  PubMed  Google Scholar 

  52. Mazza E, Kroeller D, Prosperi M et al (2013) Does ICG clearance (ICGR15) predict morbidity and mortality after hepatic resection for hepatocellular carcinoma in cirrhotic patients? Intensive Care Med Abs. Transpl Inter (Suppl 2) 185–329, S609

    Google Scholar 

  53. Zipprich A, Kuss O, Rogowski S et al (2010) Incorporating indocyanine green clearance into the model for end stage liver disease (MELD-ICG) improves prognostic accuracy in intermediate to advanced cirrhosis. Gut 59:963–968

    Article  PubMed  Google Scholar 

  54. Jalan R, Plevris JN, Jalan AR, Bzeizi KI, Dollinger MM, Lee A, Garden OJ, Hayes PC (1994) A pilot study of indocyanine green clearance as an early predictor of graft function. Transplantation 58:196–200

    Article  CAS  PubMed  Google Scholar 

  55. Plevris JN, Jalan R et al (1999) Indocyanine green clearance reflects reperfusion injury following liver transplantation and is an early predictor of graft function. J Hepatol 30:142–148

    Article  CAS  PubMed  Google Scholar 

  56. Tsubono T, Todo S, Jabbour N, Mizoe A, Warty V, Demetris AJ, Starzl TE et al (1996) Indocyanine green elimination test in orthotopic liver recipients. Hepatology 24(5):1165–1171

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  57. Faybik G, Hetz H (2006) Plasma disappearance rate of indocyanine green in liver dysfunction. Transplant Proc 38:801–802

    Article  CAS  PubMed  Google Scholar 

  58. Hori T, Lida T et al (2006) Kicg value, a reliable real–time estimator of graft function, accurately predicts outcomes in adult living-donor liver transplantation. Liver Transpl 12:605–613

    Article  PubMed  Google Scholar 

  59. Levesque E, Saliba F, Benhamida S et al (2009) Plasma disappearance rate of indocyanine green: a tool to evaluate early graft outcome after liver transplantation. Liver Transpl 15:1358–1364

    Article  PubMed  Google Scholar 

  60. Levesque E, Hoti E, Azoulay D, Saliba F et al (2011) Non-invasive ICG-clearance: a useful tool for the management of hepatic artery thrombosis following liver transplantation. Clin Transpl 25:297–301

    Article  CAS  Google Scholar 

  61. Olmedilla L, Perez-Pena JM et al (2009) Early noninvasive measurement of the indocyanine green plasma disappearance rate accurately predicts early graft dysfunction and mortality after deceased donor liver transplantation. Liver Transpl 15:1247–1253

    Article  PubMed  Google Scholar 

  62. Escorsell A, Mas A et al (2012) Limitations of use of the noninvasive clearance of indocyanine green as a prognostic indicator of graft function in liver transplantation. Transplant Proc 44:1539–1541

    Article  CAS  PubMed  Google Scholar 

  63. De Gasperi A, Mazza E, Corti A et al (1997) Lactate blood levels in the perioperative period of orthotopic liver transplantation. Int J Clin Lab Res 27:123–128

    Article  PubMed  Google Scholar 

  64. Kim GA, Bae KS, Noh GJ et al (2009) Estimation of indocyanine green elimination rate constant k and retention rate at 15 min using patient age, weight, bilirubin and albumin. J Hepatobiliary Pancreat Surg 16:521

    Article  PubMed  Google Scholar 

  65. Lock JF, Schwabauer E, Martus P et al (2010) Early diagnosis of primary nonfunction and indication for reoperation after liver transplantation. Liver Transpl 16:172–180

    Article  PubMed  Google Scholar 

  66. Jara M, Malinowski M, Lüttgert K, Schott E, Neuhaus P, Stockmann M (2015) Prognostic value of enzymatic liver function for the estimation of short-term survival of liver transplant candidates: a prospective study with the LiMAx test. Transpl Int 28:52–58

    Article  PubMed  Google Scholar 

  67. Merle U, Sieg O, Stremmel W, Encke J, Eisenbach C (2009) Sensitivity and specificity of plasma disappearance rate of indocyanine green as a prognostic indicator in acute liver failure. BMC Gastroenterol 9:91

    Article  PubMed Central  PubMed  Google Scholar 

  68. Lock JF, Kotobi AN, Malinowski M, Schulz A, Jara M, Neuhaus P, Stockmann M (2013) Predicting the prognosis in acute liver failure: results from a retrospective pilot study using the LiMAx test. Ann Hepatol 12:556–562

    PubMed  Google Scholar 

  69. Pollack DS, Sufian S, Matsumoto T (1979) Indocyanine green clearance in critically ill patients. Surg Gynecol Obstet 149:852

    CAS  PubMed  Google Scholar 

  70. Inal MT, Memis D, Kargi M, Sut N (2009) Prognostic value of indocyanine green elimination assessed with LiMON in septic patients. J Crit Care 24:329–334

    Article  PubMed  Google Scholar 

  71. Sakka SG, Reinhart K, Meier-Hellmann A (2002) Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients. Chest 122:1715–1720

    Article  PubMed  Google Scholar 

  72. Kimura S, Yoshioka T et al (2001) Indocyanine green elimination rate detects hepatocellular dysfunction early in septic shock and correlates with survival. Crit Care Med 29(6):1159–1163

    Article  CAS  PubMed  Google Scholar 

  73. An G, West MA (2008) Abdominal compartment syndrome: a concise clinical review. Crit Care Med 36:1304–1310

    Article  PubMed  Google Scholar 

  74. Gottlieb ME, Stratton HH, Newell JC et al (1984) Indocyanine green. Its use as an early indicator of hepatic dysfunction following injury in man. Arch Surg 119:264

    Article  CAS  PubMed  Google Scholar 

  75. Sakka SG (2007) Indocyanine green plasma disappearance rate as an indicator of hepato-splanchnic ischemia during abdominal compartment syndrome. Anesth Anal 104:1003–1004. 109

    Article  Google Scholar 

  76. Thumer O, Huttemann E, Sakka SG (2007) Indocyanine green plasma disappearance rate. Marker of partial hepatosplanchnic ischemia. Anaesthesist 56:339–344

    Article  CAS  PubMed  Google Scholar 

  77. Seibel A, Muller A, Sakka SG (2011) Indocyanine green plasma disappearance rate for monitoring hepatosplanchnic blood flow. Intensive Care Med 37:357–359

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 2° Servizio Anestesia e Rianimazione, Ospedale Niguarda Ca’ Granda, Piazza Ospedale Maggiore 3, Milan, 20162, Italy

    Andrea De Gasperi MD & Ernestina Mazza MD

Authors
  1. Andrea De Gasperi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ernestina Mazza MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrea De Gasperi MD .

Editor information

Editors and Affiliations

  1. Dipartimento di Anestesia, Rianimazione e Terapia del Dolore, Ospedale Maggiore Policlinico Fondazione IRCCS Ca’ Granda, Milano, Italy

    Davide Chiumello

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

De Gasperi, A., Mazza, E. (2015). Clinical Use of Indocyanine Green (ICG) Kinetics in Liver Anaesthesia and ICU. In: Chiumello, D. (eds) Practical Issues Updates in Anesthesia and Intensive Care. Springer, Cham. https://doi.org/10.1007/978-3-319-18066-3_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-18066-3_13

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-18065-6

  • Online ISBN: 978-3-319-18066-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation